Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
Authors:
- 1 December 2000
- journal article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 28 (6) , 313-317
Abstract
Blood fibrinogen concentrations and glutamic-pyruvic transaminase activities of 66 adult cancer inpatients (aged 22–70 years) were determined both before and after one or two chemotherapy regimens. The percentage of hepatoma patients with abnormal blood fibrinogen levels (< 1.5 or > 6.0 g/l) was higher (64.3% of 14 patients) than that in other cancer categories (19.2% of 52 patients). The mean blood fibrinogen concentrations of male (3.5 g/l) and female (4.5 g/l) cancer patients were higher than those previously reported for healthy humans (2.8 and 2.9 g/l, respectively). After chemotherapy, blood fibrinogen concentrations decreased in patients whose primary tumours were surgically removed (from 4.8 to 3.2 g/l) but increased (from 3.0 to 4.8 g/l) in those who did not undergo surgery. Glutamic-pyruvic transaminase activities did not appear to be related to blood fibrinogen levels. We conclude that the increase in mean blood fibrinogen levels of cancer patients is probably related to tumour growth. Different mechanisms may operate in patients with hepatoma.Keywords
This publication has 6 references indexed in Scilit:
- The role of fibrin in tumor metastasisCancer and Metastasis Reviews, 1992
- Fibrin formation on vessel walls in hyperplastic and malignant prostate tissueCancer, 1991
- Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75Cancer, 1984
- Fibrin as a component of the tumor stroma: origins and biological significanceCancer and Metastasis Reviews, 1983
- Congenital afibrinogenemia in 10 offspring of uncle‐niece marriagesClinical Genetics, 1980
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951